The phase 3 SERENA-6 trial evaluated whether replacing an aromatase inhibitor with camizestrant while continuing a CDK4/6 inhibitor in patients with ER-positive, HER2-negative advanced breast cancer and...
A recent study found that daily supplementation with myo-inositol during pregnancy did not reduce the risk of gestational diabetes, preeclampsia, or preterm birth in individuals with polycystic ovary...
In a multicenter trial of women with low-prognosis in vitro fertilization, investigators compared the effectiveness and safety of elective freeze-all versus fresh embryo transfer.
Recent findings presented at the American College of Obstetricians and Gynecologists Annual Clinical & Scientific Meeting 2025 support several effective pain-reducing methods for outpatient...
The results from a randomized, placebo-controlled trial showed that oral probiotic supplementation did not reduce the recurrence of vulvovaginal infections in pregnant women following successful treatment....
In an FDA panel held on July 21, 2025, experts discussed the nuances of risk-benefit counseling and stronger warnings for selective serotonin reuptake inhibitors (SSRIs) to ensure informed consent among...
In women aged 65 years or older post–hip fracture, testosterone plus exercise did not improve long-distance walking more than exercise alone, though researchers observed some gains.
Obstructive sleep apnea (OSA) is more prevalent and complex than often recognized—especially in women, older adults, and patients with comorbid conditions, according to Julianne Blythe, MPA, PA-C, RPSGT, a...
In a recent study, most patients who initiated urate-lowering therapy could achieve a patient-acceptable symptom state or low disease activity within 6 to12 months, with lower flare burden associated with...
